INDICATIONS AND USAGE LINZESS (linaclotide) is indicated for the treatment of: irritable bowel syndrome with constipation (IBS-C) in adults and pediatric patients 7 years of age and older chronic idiopathic constipation (CIC) in adults functional constipation (FC) in pediatric patients 6 years of age and older IMPORTANT SAFETY INFORMATION WARNING: RISK OF SERIOUS DEHYDRATION IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE LINZESS is contraindicated in patients less than 2 years of age
Cody Belkoff, DO just 10 minutes east in Liberty Lake
Overall, dual agonists are showing efficacy in both weight and cardiovascular risk reduction
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test evaluates predispositions in key metabolic and appetite-regulatory pathwaysincluding FTO rs9939609 (energy homeostasis), MC4R rs17782313 (appetite signaling), GLP1R rs6923761 (GLP-1 receptor sensitivity), and GIPR rs1800437 (GIP pathway responsiveness)
Epithalon, also known as Epitalon, is a synthetic peptide studied for its potential to support telomere maintenance and pineal gland function
These peptides are usually administered through subcutaneous injection
